EGFR and non-small cell lung carcinoma: It has also been reported to effectively decrease the cell proliferation rates of NSCLC cell lines expressing T790M mutation and showed therapeutic potential in xenograft of murine lung tumor with EGFR L858R/790M double mutations [10].